Long-term effect of intravenous thrombolytic therapy in acute stroke: responder analysis versus uniform analysis of excellent outcome

Cerebrovasc Dis. 2005;20(6):470-4. doi: 10.1159/000089334. Epub 2005 Oct 27.

Abstract

Background: Knowledge regarding functional improvement over time and long-term outcome after intravenous thrombolysis in acute ischaemic stroke is limited. The aim of this study was to compare a uniform assessment of outcome with an assessment taking the baseline stroke severity into account (responder analysis).

Methods: Fifty-seven patients were assessed with the modified Rankin Scale at 3, 6 and 12 months and a comparison was made between a uniform assessment and a responder analysis of excellent outcome.

Results: Between 3 and 12 months, 74% of the patients had a stable functional outcome and 22% improved. Excellent outcome at 12 months was similar in the uniform analysis (37%) and the responder analysis (35%). The individual patients having an excellent outcome differed, however, using the two methods. Using a responder analysis the number of patients with excellent outcome decreased in mild stroke patients by 40%, but increased in severe stroke patients by 43%.

Conclusions: Short-term outcome is sustained at 12 months, but major improvement does not occur between 3 and 12 months. A responder analysis of long-term excellent outcome provided a balanced measure of outcome reflecting the drug-related potential of improvement in all stroke severity subgroups, whereas a uniform analysis provided a measure of outcome mainly in mild stroke patients. These results suggest that a responder analysis should be considered for the assessment of outcome after treatment for acute stroke.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Data Interpretation, Statistical
  • Female
  • Fibrinolytic Agents / administration & dosage
  • Fibrinolytic Agents / therapeutic use*
  • Follow-Up Studies
  • Humans
  • Infarction, Middle Cerebral Artery / complications
  • Infarction, Middle Cerebral Artery / drug therapy
  • Injections, Intravenous
  • Male
  • Middle Aged
  • Stroke / drug therapy*
  • Thrombolytic Therapy*
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Fibrinolytic Agents